ReCode Therapeutics Appoints Trisha Millican to Board of Directors
MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today the appointment of Patricia “Trisha” Millican to the company’s Board of Directors. Ms. Millican brings over 20 years of experience in the life...
